Chaired by Professors Stephen Davis and Geoffrey Donnan, Neuroscience Trials Australia (NTA) was established in 2001 as the clinical trials platform of the National Neuroscience Facility (NNF) with the primary aim to build in Australia a world-class infrastructure for neuroscience clinical trials.

Governed by a Management Board made up of leading clinicians representing the various disease interest groups across the neurosciences, NTA plays a key role in the translation of quality research into clinical practice, resulting in better health outcomes for the Australian public.

Clinical investigators may access NTA services directly or via their disease specific interest groups, each with their own membership rules and regulations.

Industry sponsors of clinical trials may access NTA services directly.